- Home
- LUCD vs OCCI Comparison
LUCD vs OCCI Comparison
Compare LUCD & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- OCCI
- Stock Information
- Founded
- LUCD 2018
- OCCI N/A
- Country
- LUCD United States
- OCCI United States
- Employees
- LUCD N/A
- OCCI N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OCCI Trusts Except Educational Religious and Charitable
- Sector
- LUCD Health Care
- OCCI Finance
- Exchange
- LUCD Nasdaq
- OCCI Nasdaq
- Market Cap
- LUCD 140.7M
- OCCI 160.5M
- IPO Year
- LUCD 2021
- OCCI N/A
- Fundamental
- Price
- LUCD $1.26
- OCCI $6.01
- Analyst Decision
- LUCD Strong Buy
- OCCI
- Analyst Count
- LUCD 4
- OCCI 0
- Target Price
- LUCD $3.94
- OCCI N/A
- AVG Volume (30 Days)
- LUCD 1.2M
- OCCI 115.8K
- Earning Date
- LUCD 08-11-2025
- OCCI 12-11-2023
- Dividend Yield
- LUCD N/A
- OCCI 24.32%
- EPS Growth
- LUCD N/A
- OCCI N/A
- EPS
- LUCD N/A
- OCCI N/A
- Revenue
- LUCD $4,173,000.00
- OCCI N/A
- Revenue This Year
- LUCD $91.46
- OCCI N/A
- Revenue Next Year
- LUCD $213.42
- OCCI $10.19
- P/E Ratio
- LUCD N/A
- OCCI N/A
- Revenue Growth
- LUCD 39.89
- OCCI N/A
- 52 Week Low
- LUCD $0.68
- OCCI $5.47
- 52 Week High
- LUCD $1.80
- OCCI $10.15
- Technical
- Relative Strength Index (RSI)
- LUCD 46.57
- OCCI 38.33
- Support Level
- LUCD $1.21
- OCCI $6.27
- Resistance Level
- LUCD $1.34
- OCCI $6.36
- Average True Range (ATR)
- LUCD 0.08
- OCCI 0.11
- MACD
- LUCD -0.01
- OCCI 0.01
- Stochastic Oscillator
- LUCD 50.00
- OCCI 6.67
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.